All News
Filter News
Found 808,690 articles
-
Simulation Is Changing The Way That Healthcare Professionals Learn And Improve Patient Safety
9/16/2019
Healthcare simulation is rapidly changing the face of healthcare. Simulation is a technique that creates a situation or environment allowing people to experience a representation of a real event for the purpose of experiential practice, learning, testing, evaluation and understanding of systems
-
MIPS 2020 Proposed Ruling Changes and Performance Requirement Updates
9/16/2019
CMS recently released proposed changes to the Quality Payment Program (QPP), outlining MIPS changes in 2020 and beyond.
-
Health Decisions Receives 4th Consecutive Appointment as Statistical and Clinical Coordinating Center for the Contraceptive Clinical Trials Network of the NICHD
9/16/2019
Health Decisions, Inc., a full-service contract research organization specializing in women's health clinical research and diagnostic development, announced that it has been retained as the Statistical and Clinical Coordinating Center (SCCC) for the Contraceptive Clinical Trials Network (CCTN) of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a unit of the National Institutes of Health (NIH).
-
Context Therapeutics and SOLTI launch ONAWA: a Window of Opportunity Study in Breast Cancer with Apristor
9/16/2019
Context Therapeutics, a clinical-stage biopharmaceutical company dedicated to advancing medicines for hormone driven cancers, today announced a clinical collaboration with SOLTI, a leading collaborative and academic group in Spain dedicated to clinical and translational research in breast cancer.
-
Mindmed Acquires Opioid Addiction Drug Candidate Based on the Natural Psychedelic Ibogaine
9/16/2019
Mind Medicine, Inc. ("Mindmed"), the leading neuro-pharmaceutical company focused on discovering and developing medicines based on psychedelics, has finalized the acquisition of the 18-MC drug development program, an anti-addictive molecule that was previously funded by the National Institute on Drug Abuse ("NIDA")
-
Children’s Hospital Los Angeles Leads First Randomized Clinical Trial to Show Positive Results in Rhabdomyosarcoma in 45 Years
9/16/2019
A phase 2 clinical trial has found that combining a molecular targeted drug called temsirolimus with chemotherapy shows promise in the treatment of rhabdomyosarcoma, the most common soft tissue sarcoma in childhood
-
IFF Celebrates Opening of New Innovation Center in Holmdel’s Historic Bell Works
9/16/2019
IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF), a leading innovator of taste, scent, nutrition and ingredients today opens the doors to its Home & Fabric Care Innovation Center at Bell Works in Holmdel, New Jersey.
-
FDA Clears ARTIS icono Family of Angiography Systems From Siemens Healthineers
9/16/2019
The U.S. Food and Drug Administration (FDA) has cleared the ARTIS icono, a high-precision family of angiography systems from Siemens Healthineers that permit a wide range of minimally invasive procedures to be performed in a single interventional suite.
-
SillaJen Defending Position Relating to Recent Sale of Stock by Employee
9/16/2019
SillaJen, Inc., (KOSDAQ:215600), a clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, today affirmed that the company is fully cooperating with the Joint Securities Crime Investigation Division of the Southern Seoul Prosecutors Office, over allegations that an employee sold shares recently using undisclosed information, which would constitute a violation of the law.
-
Amp Human and Team Charles-Barclay Launch Partnership
9/16/2019
Amp Human, creators of PR Lotion, announced today the addition of Lucy Charles-Barclay and Reece Barclay to its athlete team.
-
Kas Subramanian, PhD Joins Applied BioMath, LLC as Senior Director of Preclinical Modeling
9/16/2019
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, is proud to welcome Kas Subramanian, PhD as Senior Director of Preclinical Modeling.
-
Peach Bowl, Inc. Makes Historic Donation to Children's Healthcare of Atlanta to Fight Childhood Cancer
9/16/2019
Peach Bowl, Inc. is joining the fight against childhood cancer, and it is all in.
-
Jackson Physician Search's Angela Henry Earns Fellow of American College of Healthcare Executives (FACHE) Credential
9/16/2019
Vice President of Firm's Physician Leader Search Team Receives Prestigious Designation and Board Certification in Healthcare Management
-
Exeltis USA, Inc. Announces the Launch of Slynd™(drospirenone) tablets, 4 mg, the First and Only Progestin-Only Pill Providing Pregnancy Prevention with a 24-hour missed pill window and 24/4 Dosing Regimen
9/16/2019
Exeltis USA, Inc. a division of Insud Pharma (headquartered in Madrid, Spain) today announced the commercial launch of its oral contraceptive tablet Slynd™ (drospirenone) tablets, 4 mg in the US market.
-
Hyundai Hope On Wheels Presents University Of Michigan C.S. Mott Children's Hospital With Hyundai Young Investigator And Scholar Hope Grant Totaling $500,000 To Support Pediatric Cancer Research
9/16/2019
The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research
-
Tiziana Life Sciences Announces FDA Approval to Initiate Phase I Clinical Trial with Orally Administered Foralumab in Healthy Volunteers
9/16/2019
A breakthrough approach for treatment of autoimmune and inflammatory diseases
-
Sage Growth Partners Retained by Inspirata for Strategic Marketing Communications Services
9/16/2019
Cancer informatics company selected Sage for recently completed positioning, messaging, and website design
-
Tantalus Labs Launches Proprietary Limited Release Cannabis Cultivar
9/16/2019
Tantalus Labs Ltd. ("Tantalus Labs"), a B.C.-based licensed cannabis producer known for their proprietary genetics and established product lines, have expanded their offerings into a new, exclusive and limited release cannabis product
-
Harmony Biosciences To Present Clinical Data On WAKIX® (pitolisant) At Upcoming World Sleep 2019
9/16/2019
Harmony Biosciences, LLC (Harmony) announced today it will present clinical data on the efficacy and safety of WAKIX® (pitolisant) at the World Sleep 2019 meeting in Vancouver, Canada from September 20-25, 2019
-
The iQ Group Global acquires new anticancer drug platform from University of Texas
9/16/2019
Added a novel anticancer drug platform to its portfolio that has the ability to develop a range of cancer therapeutics.